Company: NCEL
Filing Date: 2025-11-06
Form Type: POS AM
Source: 0001213900-25-106799
Chunk: 70

Company: NewcelX Ltd.
Filing Date: 2025-11-06
Form: POS AM
Chunk 70
---
.
NOTES TO THE UNAUDITED INTERIM CONDENSED FINANCIAL STATEMENTS

Warrants During the six months ended June 30, 2025, the Company had the following common share warrant issuances: • 1,181,818warrants with an exercise price of $ 1.80per share exercisable for five years in the March 2025 SPA • 192,308pre -fundedwarrants as a commitment fee pursuant to an equity line of credit executed with Alpha • 485,000pre -fundedwarrants pursuant to a make whole provision in the March 2025 SPA

The following table summarizes the common share warrant activity for the six-month period ended June 30, 2025:

|                                                      |     |    Shares |   |     | Weighted 
 Average  
 Exercise 
 Price    |       |     |    Weighted 
     Average 
 Contractual 
        Term |
|:-----------------------------------------------------|:----|----------:|:--|:----|:---------|------:|:----|------------:|
| Balance at January 1, 2025                           |     | 1,598,962 |   |     | $        | 16.44 |     |        3.32 |
| Issuances                                            |     | 1,859,126 |   |     |          |  1.16 |     |             |
| Exercises                                            |     |   (76,817 | ) |     |          |  1.43 |     |             |
| Balance outstanding and exercisable at June 30, 2025 |     | 3,381,241 |   |     | $        |  8.38 |     |        3.00 |

The intrinsic value of exercisable but unexercised in -the-moneycommon share warrants at June 30, 2025 was $ 5,188,448. Option Plan On December 14, 2021, the Board of Directors adopted the Share Option Plan Regulation 2021 (the “Option Plan”). The purpose of the Option Plan is to retain, attract and motivate management, employees, directors and consultants by providing them with options to purchase common shares. The Board of Directors allocated fifteen percent ( 15%) of the Company’s fully diluted shares to awards that may be made pursuant to the Option Plan. The exercise prices, vesting and other restrictions of the awards to be granted under the Option Plan are determined by